Source: Virtual Congress 2021 – Accurate diagnosis and prediction of malignant pleural disease



Rating:

Share or cite this content

Citations should be made in the following way:
S. Alderazi (Birmingham (West Midlands), United Kingdom), A. Karanuatilleke (Birmingham (West Midlands), United Kingdom), B. Sutton (Birmingham (West Midlands), United Kingdom). Variation in outcomes for M1a Stage Lung cancers- Outcome in Malignant Pleural Effusion significantly worse than patients with Contralateral Lung Nodules. 3101

Member's Comments

No comment yet.

Related content which might interest you: Value of Transbronchial Lung Cryobiopsy in Patients Suspicious of Peripheral Lung Cancer Source: Virtual Congress 2020 – The hot and cold of interventional pulmonology Year: 2020 Characteristics of Patients with Large-Cell Neuroendocrine Carcinoma of the Lung Source: International Congress 2019 – Biology and prognosis of lung cancer Year: 2019 Hemorrhagic malignant pleural effusion: Diagnosis, survival rate, and response to talc pleurodesis Source: International Congress 2014 – Diagnosis of pleural effusions and mediastinal adenopathies Year: 2014 Predictive parameters of survival in malignant pleural effusion Source: International Congress 2015 – Malignant pleural effusions and mesothelioma Year: 2015 Risk of occult pleural infection in patients with malignant effusions Source: Annual Congress 2013 –Diagnosis and management of pleural and mediastinal diseases Year: 2013 Efficacy And Safety Of Thoracoscopic Cryobiopsy In Patients With Undiagnosed Exudative Pleural Effusion Source: Virtual Congress 2020 – Interventional pulmonology: the pleura and bronchoscopic treatment of emphysema Year: 2020 Management of recurrent Malignant Pleural Effusion: what is the best method? Source: ERS Course 2015 Year: 2015 Management of recurrent Malignant Pleural Effusion: what is the best method? Source: School Course 2014 - Thoracoscopy and Pleural Techniques Year: 2014 Management of spontaneous pneumothorax in patients with or without Birt-Hogg-Dubé syndrome Source: International Congress 2014 – ILDs 1 Year: 2014 Survival of non small cell lung carcinoma patients with malignant pleural effusions Source: International Congress 2014 – Therapy of thoracic tumours: clinical trials and case series Year: 2014 Role of fibulin-3 in the diagnosis of malignant mesothelioma Source: International Congress 2014 – Diagnosis and treatment of pleural mesothelioma Year: 2014 Thoracoscopy: Outcomes in non-diagnostic procedures Source: International Congress 2014 – Diagnosis of pleural effusions and mediastinal adenopathies Year: 2014 Validity of Pleural Fluid Protein in differentiating Tuberculous from Malignant Pleural Effusion Source: International Congress 2019 – Pleural infection and complicated pneumonia Year: 2019 Haematologic parameters and their prognostic impact in malignant pleural mesothelioma Source: International Congress 2014 – Diagnosis of pleural effusions and mediastinal adenopathies Year: 2014 Pleural effusions after cardiac surgery: Etiology and outcomes Source: International Congress 2016 – Open problems in thoracic surgery Year: 2016 Pleural mesothelioma: Our experience in 132 cases Source: International Congress 2014 – Diagnosis and treatment of pleural mesothelioma Year: 2014 Neuroendocrine cell hyperplasia (NEHI) and NEHI Syndrome: Lung biopsy necessary? Source: International Congress 2014 – ILDs 4 Year: 2014 Clinical Features and Treatment Outcome of Carcinomatous Pericarditis due to Lung Cancer. Source: International Congress 2018 – Lung cancer: modern therapies and beyond Year: 2018 Pleural complicationsin patients with chronic and end-stage renal disease Source: International Congress 2014 – Clinical management of lung diseases: from bronchi to pleura Year: 2014